QUOTE AND NEWS
StreetInsider.com  May 2  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/RAIT+Financial+Trust+%28RAS%29+Misses+Q1+EPS+by+3c/8297685.html for the full story.
StreetInsider.com  Apr 8  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Dividends/Compass+Point+Raises+Target+on+Rait+Financial+%28RAS%29%3B+Cash+Flow+Leads+to+Better+Dividend/8238449.html for the full story.
StreetInsider.com  Mar 28  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/RAIT+Financial+Trust+%28RAS%29+Prices+Larger+8M+Common+Stock+Offering/8217083.html for the full story.
StreetInsider.com  Mar 27  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Equity+Offerings/RAIT+Financial+%28RAS%29+Commences+7M+Common+Share+Offering/8215676.html for the full story.
StreetInsider.com  Mar 18  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Dividends/RAIT+Financial+Trust+%28RAS%29+Raises+Quarterly+Dividend+20%25+to+%240.12%3B+6.5%25+Yield/8191227.html for the full story.
Forbes  Feb 27  Comment 
In trading on Wednesday, shares of RAIT Financial Trust's 7.75% Series A Cumulative Redeemable Preferred Shares (NYSE: RAS.PRA) were yielding above the 8% mark based on its quarterly dividend (annualized to $1.9375), with shares changing hands as...
Forbes  Feb 25  Comment 
On 2/27/13, RAIT Financial Trust's 8.375% Series B Cumulative Redeemable Preferred Shares (NYSE: RAS.PRB) will trade ex-dividend, for its quarterly dividend of $0.5234, payable on 4/1/13. As a percentage of RAS.PRB's recent share price of $25.04,...
Forbes  Feb 14  Comment 
In this series, we look through the most recent Dividend Channel ''DividendRank'' report, and then we cherry pick only those companies that have experienced insider buying within the past six months. The officers and directors of a company tend to...
MedPage Today  Feb 13  Comment 
(MedPage Today) -- The novel kinase inhibitor selumetinib sensitized advanced thyroid cancer to radioiodine, particularly in disease with RAS mutations, a small, proof-of-concept study found.
StreetInsider.com  Feb 13  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/RAIT+Financial+Trust+%28RAS%29+Tops+Q4+FFO+by+3c/8088789.html for the full story.




RELATED WIKI ARTICLES
 
TOP CONTRIBUTORS

RAIT Financial Trust (RAS, formerly known as RAIT Investment Trust) is a real estate investment trust (REIT) that primarily engages in the lending aspects of the real estate business. RAS attempts to generate returns for shareholders by investing in the following asset classes 1) commercial mortgages and mezzanine loans 2) trust preferred securities, 3) residential mortgage loans 4) mortgage backed securities 5) real estate investments and preferred equity in entities that own real estate.

The company generates income for shareholders from interest and dividend income from its investment portfolio, origination fees, and asset management fees. The company's income is generated from net investment income, the difference between interest income on their investment portfolio and the cost of financing the portfolio. Most of the company's portfolio is financed through borrowings and securitizations. RAS uses warehouse agreements, CDOS, and lines of credit to finance the majority of its investments.

As of September 30, 2007, the company's investment portfolio stood at $12.3 billion, including $4.8 billion relating to trust preferred securities ("TruPS") and subordinated debentures $2.3 billion in commercial mortgages and mezzanine loans $4.2 billion in residential mortgages and mortgage-related receivables and $0.3 billion of other real estate related investments. The underlying property types of the company's real estate loans are broken down as follows: 51% multifamily, 25% office properties, 18% retail, 5% other assets, and 1% industrial.




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki